Around 80% of TTP is activated by deficient activity of ADAMTS13. ADAMTS13 deficiency is often constitutive, as a result of biallelic ADAMTS13 pathogenic variants; or acquired, due to an inhibitory antibody. Evaluation of ADAMTS13 action is executed working with tests based upon the aptitude in the protease to cleave normal VWF multimers in vitro (